ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
gedck
|
62 |
17K |
26 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
62
|
17K
|
26
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Clarification - Scheme Booklet registered with ASIC
|
|
gedck
|
29 |
8.2K |
21 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
29
|
8.2K
|
21
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate extends licence agreement and plans to expand use
|
|
gedck
|
151 |
50K |
13 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
151
|
50K
|
13
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx
|
|
gedck
|
126 |
37K |
18 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
126
|
37K
|
18
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Cough detection patent granted in Australia and Japan
|
|
gedck
|
47 |
14K |
26 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
47
|
14K
|
26
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
gedck
|
425 |
125K |
22 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
425
|
125K
|
22
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
gedck
|
118 |
37K |
33 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
118
|
37K
|
33
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
gedck
|
3.3K |
2.5M |
2 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
3.3K
|
2.5M
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
gedck
|
466 |
160K |
24 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
466
|
160K
|
24
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
gedck
|
1.0K |
295K |
3 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
1.0K
|
295K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
gedck
|
1.0K |
295K |
10 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
1.0K
|
295K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
gedck
|
3.3K |
2.5M |
0 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
3.3K
|
2.5M
|
0
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
gedck
|
3.3K |
2.5M |
25 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
3.3K
|
2.5M
|
25
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
gedck
|
1.0K |
295K |
4 |
22/12/21 |
22/12/21 |
ASX - By Stock
|
1.0K
|
295K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar Presentation
|
|
gedck
|
159 |
44K |
7 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
159
|
44K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Results and Investor Conference Call Notification
|
|
gedck
|
32 |
9.7K |
6 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
32
|
9.7K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Clinical study to develop COVID-19 screening test
|
|
gedck
|
118 |
36K |
4 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
118
|
36K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
British journal of GPs ...pneumonia
|
|
gedck
|
28 |
10K |
23 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
28
|
10K
|
23
|
|
ASX - By Stock
|
AJX |
Re:
General
|
|
gedck
|
1.4K |
609K |
14 |
06/12/19 |
06/12/19 |
ASX - By Stock
|
1.4K
|
609K
|
14
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
gedck
|
100 |
57K |
6 |
01/10/19 |
01/10/19 |
ASX - By Stock
|
100
|
57K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Resapp - Gold Coast Investment Showcase
|
|
gedck
|
91 |
44K |
5 |
28/06/19 |
28/06/19 |
ASX - By Stock
|
91
|
44K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Results from Australian Adult Clinical Study
|
|
gedck
|
324 |
167K |
15 |
12/06/19 |
12/06/19 |
ASX - By Stock
|
324
|
167K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Paediatric Study Published In Peer-Reviewed Journal
|
|
gedck
|
275 |
133K |
15 |
06/06/19 |
06/06/19 |
ASX - By Stock
|
275
|
133K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp Partners with Lockheed Martin for DARPA Research
|
|
gedck
|
152 |
78K |
8 |
16/08/18 |
16/08/18 |
ASX - By Stock
|
152
|
78K
|
8
|
|
ASX - By Stock
|
NTI |
Publication?!
|
|
gedck
|
17 |
8.4K |
22 |
23/06/18 |
23/06/18 |
ASX - By Stock
|
17
|
8.4K
|
22
|
|
ASX - By Stock
|
RAP |
Re:
of interest
|
|
gedck
|
14 |
7.5K |
30 |
23/11/17 |
23/11/17 |
ASX - By Stock
|
14
|
7.5K
|
30
|
|
Charts
|
RAP |
Re:
AGM - Questions answered
|
|
gedck
|
30 |
13K |
2 |
04/11/16 |
04/11/16 |
Charts
|
30
|
13K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Update on US Clinical Study-RAP.AX
|
|
gedck
|
236 |
82K |
8 |
30/06/16 |
30/06/16 |
ASX - By Stock
|
236
|
82K
|
8
|
|
ASX - By Stock
|
HHI |
Re:
Ann: Dispatch of Prospectus-VPC.AX
|
|
gedck
|
59 |
10K |
0 |
21/06/16 |
21/06/16 |
ASX - By Stock
|
59
|
10K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Dr Keating Email Interview
|
|
gedck
|
107 |
49K |
3 |
16/05/16 |
16/05/16 |
ASX - By Stock
|
107
|
49K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Dr Keating Email Interview
|
|
gedck
|
107 |
49K |
9 |
15/05/16 |
15/05/16 |
ASX - By Stock
|
107
|
49K
|
9
|
|
ASX - By Stock
|
HHI |
Re:
Ann: VELPIC RELEASES VERSION 3.0 OF E-LEARNING PLATFORM-VPC.AX
|
|
gedck
|
62 |
9.2K |
6 |
02/05/16 |
02/05/16 |
ASX - By Stock
|
62
|
9.2K
|
6
|
|
ASX - By Stock
|
AJX |
Re:
Ann: Shareholder Newsletter
|
|
gedck
|
92 |
25K |
13 |
30/03/16 |
30/03/16 |
ASX - By Stock
|
92
|
25K
|
13
|
|
ASX - By Stock
|
RAP |
Re:
Tencent's online hospital
|
|
gedck
|
9 |
3.9K |
10 |
19/12/15 |
19/12/15 |
ASX - By Stock
|
9
|
3.9K
|
10
|
|
ASX - By Stock
|
TFC |
TFS is the market leader in a $1 Billion market
|
|
gedck
|
0 |
472 |
9 |
06/11/15 |
06/11/15 |
ASX - By Stock
|
0
|
472
|
9
|
|